These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1347453)

  • 21. The potential role of somatostatin analogues in breast cancer treatment.
    Pollak M
    Yale J Biol Med; 1997; 70(5-6):535-9. PubMed ID: 9825480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.
    Colao A; Pivonello R; Cappabianca P; Briganti F; Tortora F; Auriemma RS; De Martino MC; Marzullo P; Lombardi G
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):342-9. PubMed ID: 16117824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of iodinated somatostatin analogues selective for hsst2 and hsst5 with excellent inhibition of growth hormone and prolactin release from rat pituitary cells.
    Moore SB; van der Hoek J; de Capua A; van Koetsveld PM; Hofland LJ; Lamberts SW; Goodman M
    J Med Chem; 2005 Oct; 48(21):6643-52. PubMed ID: 16220980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic use of somatostatin analogues in endocrinology].
    Faglia G; Arosio M
    Recenti Prog Med; 1992 Nov; 83(11):626-33. PubMed ID: 1363150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role for somatostatin analogues in breast cancer: rationale and description of an ongoing trial.
    Pollak M; Gallant K; Poisson R; Harris A
    Metabolism; 1992 Sep; 41(9 Suppl 2):119-20. PubMed ID: 1355585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide.
    Wiedermann CJ; Reinisch N; Niedermühlbichler M; Braunsteiner H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):336-41. PubMed ID: 8097570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of ophthalmoplegia in acromegaly with the somatostatin analogue SMS 201-995.
    van Liessum PA; Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
    Neth J Med; 1988 Jun; 32(5-6):289-92. PubMed ID: 2899298
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach.
    Koutsilieris M; Bogdanos J; Milathianakis C; Dimopoulos P; Dimopoulos T; Karamanolakis D; Halapas A; Tenta R; Katopodis H; Papageorgiou E; Pitulis N; Pissimissis N; Lembessis P; Sourla A
    Expert Opin Investig Drugs; 2006 Jul; 15(7):795-804. PubMed ID: 16787142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and function of somatostatin receptors in growth hormone control.
    Shimon I; Melmed S
    J Endocrinol; 1997 Oct; 155 Suppl 1():S3-6; discussion S7-8. PubMed ID: 9389989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Novel pharmacologic therapies in acromegaly].
    Góth M; Hubina E; Kovács L; Szabolcs I
    Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical therapy with somatostatin analogues for acromegaly.
    Sassolas G
    Eur J Endocrinol; 1995 Dec; 133(6):675-7. PubMed ID: 8548050
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth hormone excess with onset in adolescence: clinical appearance and long-term treatment outcome.
    Colao A; Pivonello R; Di Somma C; Tauchmanovà L; Savastano S; Lombardi G
    Clin Endocrinol (Oxf); 2007 May; 66(5):714-22. PubMed ID: 17388794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly.
    Colao A; Auriemma RS; Pivonello R
    Pituitary; 2016 Apr; 19(2):210-21. PubMed ID: 26290466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of growth of PC-82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [D-Trp6]-luteinizing hormone-releasing hormone and somatostatin analog RC-160.
    Milovanovic SR; Radulovic S; Groot K; Schally AV
    Prostate; 1992; 20(4):269-80. PubMed ID: 1376910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin analogs in the treatment of acromegaly.
    Lamberts SW; Reubi JC; Krenning EP
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):737-52. PubMed ID: 1355729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of diabetic retinopathy with somatostatin analogues].
    Lang GE
    Ophthalmologe; 2004 Mar; 101(3):290-3. PubMed ID: 15007609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New treatment approaches for prostate cancer based on peptide analogues.
    Stangelberger A; Schally AV; Djavan B
    Eur Urol; 2008 May; 53(5):890-900. PubMed ID: 18201818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of somatostatin analogues in the treatment of neuroendocrine tumours based on the results of recent clinical trials].
    Igaz P
    Orv Hetil; 2014 Nov; 155(48):1908-12. PubMed ID: 25417137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.